Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
54.24B | 51.39B | 47.87B | 41.83B | 39.25B | 43.33B | Gross Profit |
17.08B | 15.64B | 14.02B | 12.21B | 11.48B | 11.91B | EBIT |
5.27B | 4.31B | 3.29B | 1.69B | 1.14B | 771.00M | EBITDA |
7.09B | 6.62B | 4.92B | 3.32B | 2.83B | 2.35B | Net Income Common Stockholders |
3.70B | 3.06B | 2.06B | 995.00M | -61.00M | 278.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
15.03B | 16.58B | 14.99B | 12.75B | 11.54B | 349.00M | Total Assets |
75.05B | 73.48B | 64.93B | 59.94B | 56.22B | 55.14B | Total Debt |
6.89B | 7.25B | 7.55B | 7.76B | 8.61B | 6.39B | Net Debt |
-8.15B | -6.33B | -7.45B | -4.99B | -2.61B | -3.18B | Total Liabilities |
30.25B | 31.09B | 28.86B | 26.25B | 24.31B | 23.89B | Stockholders Equity |
41.31B | 39.34B | 33.21B | 30.78B | 29.44B | 28.94B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.08B | 4.50B | 2.87B | 1.56B | 1.88B | Operating Cash Flow |
0.00 | 4.46B | 5.64B | 3.78B | 3.14B | 3.69B | Investing Cash Flow |
0.00 | -1.43B | -2.04B | -712.00M | -2.16B | -2.27B | Financing Cash Flow |
0.00 | -1.50B | -1.69B | -1.51B | 318.00M | -379.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥459.72B | 14.70 | 6.10% | 4.11% | 0.28% | -10.20% | |
76 Outperform | ¥24.79B | 6.46 | 4.67% | 8.77% | 32.52% | ||
74 Outperform | $9.80T | 39.92 | 10.53% | 0.76% | 9.25% | 26.69% | |
73 Outperform | ¥90.44B | 17.13 | 5.43% | 1.06% | -4.26% | ||
71 Outperform | $1.94T | 17.25 | 25.94% | 0.89% | 23.00% | ― | |
69 Neutral | $1.50T | 17.00 | 12.94% | 1.61% | 15.31% | ― | |
64 Neutral | $4.44B | 11.99 | 5.16% | 249.23% | 4.01% | -11.87% |